Corcept Therapeutics Inc
Corcept Therapeutics Inc logo
CORT

Corcept Therapeutics Inc (CORT)

$24.941.34%

Market is closed
– opens on 8 PM, 02 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$24.64
Day's Range
$25.27
$15.83
52-Week Range
$30.14
1 month return13.52%
3 month return2.69%
1 year return16.49%
5 year return49.52%

Company Information

Corcept is a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the hormone cortisol. Korlym® was the first drug approved by the U.S. Food and Drug Administration for patients with Cushing's syndrome. Corcept has discovered a large portfolio of proprietary compounds that selectively modulate the effects of cortisol. The company owns extensive United States and foreign intellectual property covering the composition of its selective cortisol modulators and the use of cortisol modulators to treat a variety of serious disorders.
OrganizationCorcept Therapeutics Inc
Employees238
CEODr. Joseph K. Belanoff M.D.
IndustryHealth Technology

Analyst Recommendation

based on 4 analysts ratings

Buy
50%
Buy
25%
Hold
25%
Sell

Based on 4 Wall street analysts offering stock ratings for Corcept Therapeutics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 28.99%

Current

$24.94

Target

$32.17

Recommendation Trend

Based on 4 analyst

Current1M Ago3M Ago
Buy
2
9
10
Hold
1
2
1
Sell
1
1
1
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
2.7B
Book Value
$4.4
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
1.0
PE Ratio
25.28
PEG Ratio
0.61
Wall Street Target Price
32.17

Valuation

Trailing PE25.28
Forward PE23.75
Price/Book (mrq)
5.94
Enterprise Value
2.4B
Enterprise Value/Revenue
6.07
Enterprise Value/Ebitda
18.6

Technicals

Beta
0.55
50 Day MA
26.64
200 Day MA
24.71

Institutional Holdings

Vanguard Group Inc

9.6%

Renaissance Technologies Corp

7.28%

Ingalls & Snyder LLC

6.46%

Federated Hermes Inc

5.14%

State Street Corporation

3.22%

Parallel Advisors, LLC

2.53%

Discover more

Frequently Asked Questions

What is Corcept Therapeutics Inc share price today?

Can Indians buy Corcept Therapeutics Inc shares?

How can I buy Corcept Therapeutics Inc shares from India?

Can Fractional shares of Corcept Therapeutics Inc be purchased?

What are the documents required to start investing in Corcept Therapeutics Inc stocks?

What are today’s High and Low prices of Corcept Therapeutics Inc?

What are today’s traded volumes of Corcept Therapeutics Inc?

What is today’s market capitalisation of Corcept Therapeutics Inc?

What is the 52 Week High and Low Range of Corcept Therapeutics Inc?

How much percentage Corcept Therapeutics Inc is down from its 52 Week High?

How much percentage Corcept Therapeutics Inc is up from its 52 Week low?

What are the historical returns of Corcept Therapeutics Inc?

Who is the Chief Executive Officer (CEO) of Corcept Therapeutics Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*